Basilea

(COMUNICADO DE PRENSA) DÜBENDORF, 8-Feb-2022 — /EuropaWire/ — Empa, el instituto de investigación suizo para la ciencia y la tecnología aplicadas a los materiales, ha anunciado que su equipo de investigación ha demostrado cómo el uso de aerogeles como aislamiento … Read the full press release →

BASEL, 11-Dec-2018 — /EuropaWire/ — Basilea Pharmaceutica Ltd. (SIX: BSLN) announced today that the sales of the antifungal Cresemba® (isavuconazole) by Astellas Pharma Inc. (“Astellas”) in the United States exceeded the threshold triggering a milestone payment to Basilea in the amount of … Read the full press release →

BASEL, 05-Mar-2018 — /EuropaWire/ — Basilea Pharmaceutica Ltd. (SIX: BSLN) announced today that Adesh Kaul will join Basilea’s Management Committee as Chief Corporate Development Officer effective March 01, 2018. He will continue to be responsible for strategic planning, business development & … Read the full press release →

BASEL, 02-Oct-2017 — /EuropaWire/ — Basilea Pharmaceutica Ltd. (SIX: BSLN) announced today that Basilea Pharmaceutica International Ltd. (Basilea) has entered into a license agreement with Shenzhen China Resources Gosun Pharmaceutical Co., Ltd. (CR Gosun) for Basilea’s antibiotic Zevtera®(ceftobiprole) in China, Hong … Read the full press release →

BASEL, 09-Jun-2017 — /EuropaWire/ — Basilea Pharmaceutica Ltd. (SIX: BSLN) announced today that updates were presented on the ongoing clinical phase 1/2a program with its anticancer drug candidate BAL101553, a novel tumor checkpoint controller, at the American Society of Clinical Oncology … Read the full press release →

Basel, Switzerland, 24-11-2014 — /EuropaWire/ — Basilea Pharmaceutica Ltd. (SIX: BSLN) reports today that the U.S. Food and Drug Administration (FDA) announced a public meeting of the Anti-Infective Drugs Advisory Committee to discuss the New Drug Application (NDA) for the investigational … Read the full press release →

Basel, Switzerland, 11-12-2013 — /EuropaWire/ — Basilea Pharmaceutica Ltd. (SIX: BSLN) announced today that the U.S. Food and Drug Administration (FDA) designated isavuconazole as a Qualified Infectious Disease Product (QIDP) for the treatment of invasive aspergillosis. QIDP status provides priority review and … Read the full press release →

Continued improvement in financial performance Cash and short-term investments of CHF 262.8 million Guidance on isavuconazole phase 3 topline data and ceftobiprole regulatory decision in Europe maintained for H2 2013 Significant agreement with BARDA of up to USD 89 million … Read the full press release →

BAL30072 current multiple ascending dose study reached maximum tolerated dose Further development, including combination studies with carbapenems, planned under BARDA agreement Basel, Switzerland, 26-6-2013 — /europawire.eu/ — Basilea Pharmaceutica Ltd. (SIX: BSLN) announced today that the Biomedical Advanced Research and Development … Read the full press release →

“El beneficio antes de provisiones alcanzó 23.559 millones de euros, lo que sitúa a Banco Santander como el tercer banco del mundo y muestra la capacidad de generación de beneficios que tiene el grupo una vez se normalice el nivel … Read the full press release →

Antonio TAJANI – Vicepresidente della Commissione europea, responsabile per l’Industria e l’Imprenditoria Berlaymont / Bruxelles 10-1-2013 — /europawire.eu/ — 1. Una rivoluzione culturale La Commissione ha adottato questa mattina il piano d’azione “Imprenditoria 2020”. Vorrei innanzitutto ringraziare i Vice Presidenti Vivian Reding e … Read the full press release →

Basel, Switzerland, 3-1-2013 — /europawire.eu/ — Basilea Pharmaceutica Ltd. (“Basilea”, SIX:BSLN) and its partner Astellas Pharma Inc. (“Astellas”) announced today that patient recruitment for the isavuconazole phase 3 registration study SECURE has been completed. Isavuconazole is an investigational intravenous (i. v.) … Read the full press release →

Il Vicepresidente della Commissione europea Antonio Tajani inaugura la Settimana delle PMI e del Mercato unico Sala della Protomoteca, Campidoglio/Roma, 18-10-2012 — /europawire.eu/ — INTRODUZIONE Il Nobel attribuito all’Unione europea è un riconoscimento alla pace e alla prosperità realizzata con oltre sessant’anni … Read the full press release →